Page 1

2025-02-02 10:09 כ . Annual General Meeting -Trading update Dechra Annual General Meeting -Trading update Released 21 Oct 2021 07:00 RNS Number : 7344P Dechra Pharmaceuticals PLC 21 October 2021 Thursday , 21 October 2021 DechraⓇ Pharmaceuticals PLC ( Dechra , Group , Company ) Annual General Meeting Trading update The Board of Dechra issues the following statement prior to the Annual General Meeting ( AGM ) which will take place at the Company's offices at 6 Cheshire Avenue , Cheshire Business Park , Lostock Gralam , Northwich , CW9 7UA at 9.30 am today , Thursday 21 October 2021 : Trading in the first quarter of the financial year was strong , especially in the US as we continued to outperform the sector and benefit from strong growth in the Companion Animal market . Although trading is currently encouraging , it remains too early in the year to extrapolate this performance across the full year . No other new trading updates are to be made at the AGM today . Dechra will announce its interim results for the six month period to 31 December 2021 on 21 February 2022 . Enquiries : Dechra Pharmaceuticals PLC lan Page , Chief Executive Officer Paul Sandland , Chief Financial Officer e - mail : corporate.enquiries@dechra.com Office : +44 ( 0 ) 1606 814 730 Office : +44 ( 0 ) 1606 814 730 TooleyStreet Communications Ltd Fiona Tooley , Director e - mail : fiona@tooleystreet.com https://otp.investis.com/clients/uk/dechra/rns/regulatory-story.aspx?cid=1758&newsid=1518993 Mobile : +44 ( 0 ) 7785 703 523 Office : +44 ( 0 ) 121 309 0099 1/2 12